–News Direct–
By Jeremy Golden, Benzinga
Syra Healths (NASDAQ: SYRA) new deal to collect data and acquire information related to Healthcare Effectiveness Data and Information Set (HEDIS) will further the Carmel, Indiana-based companys goal of providing innovative services and technology solutions in the healthcare sector.
Developed and maintained by the National Committee for Quality Assurance (NCQA), HEDIS is a standardized population health management tool that employers can use to understand employee health and measure the quality of care their population receives. HEDIS plays a critical role in healthcare quality measurement and improvement initiatives as the most widely used performance improvement tool in healthcare.
As per the agreement, Syra Health will provide HEDIS outreach and support services essential for fostering positive health outcomes and reducing costs.
Syra Health, whose products and services are centered on prevention, improved access and affordable care, will leverage its team of population health experts to collect data and acquire information from the Indiana population, including Medicaid members, hospitals and physicians.
"The need for robust data and analytics by healthcare decision-makers is continuing to expand, said Dr. Deepika Vuppalanchi, CEO, Syra Health. We are proud that we are being recognized for our strong team of health experts.
We remain steadfast in pursuing and securing important contracts for our services and products, added Sandeep Allam, Executive Chairman and President, Syra Health. Our contract pipeline is growing, and we look forward to sharing more contracts as they are fully executed.
Featured photo by Matheus Ferrero on Unsplash.
Syra Health is a healthcare technology company addressing some of healthcare's most significant challenges in areas such as behavioral and mental health, digital health, and population health, by providing innovative services and technology solutions. Syra Healths products and services are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and government. For more information, please visit www.syrahealth.com.
Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include, but are not limited to, statements relating to the expected use of proceeds, the Companys operations and business strategy and the Companys expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty and changes in circumstances. Investors should read the risk factors set forth in our registration statement on Form S-1 and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.
This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.
Contact Details
Christine Drury
+1 463-345-8950
Company Website
View source version on newsdirect.com: https://newsdirect.com/news/syra-health-nasdaq-syra-wins-650-000-healthcare-quality-improvement-contract-773288493
Syra Health
COMTEX_448946236/2655/2024-03-08T08:29:41
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Euro Currents journalist was involved in the writing and production of this article.